• English
    • français
    • Deutsch
    • español
    • português (Brasil)
    • Bahasa Indonesia
    • русский
    • العربية
    • 中文
  • English 
    • English
    • français
    • Deutsch
    • español
    • português (Brasil)
    • Bahasa Indonesia
    • русский
    • العربية
    • 中文
  • Login
View Item 
  •   Home
  • OAI Data Pool
  • OAI Harvested Content
  • View Item
  •   Home
  • OAI Data Pool
  • OAI Harvested Content
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

All of the LibraryCommunitiesPublication DateTitlesSubjectsAuthorsThis CollectionPublication DateTitlesSubjectsAuthorsProfilesView

My Account

LoginRegister

The Library

AboutNew SubmissionSubmission GuideSearch GuideRepository PolicyContact

Status of a Unique Vaccine against hCG for Contraception and Advanced Stage Cancers expressing ectopically hCG

  • CSV
  • RefMan
  • EndNote
  • BibTex
  • RefWorks
Author(s)
Talwar GP
Singh P
Gupta JC

Full record
Show full item record
URI
http://hdl.handle.net/20.500.12424/692575
Online Access
http://www.kup.at/kup/pdf/13105.pdf
Abstract
Dear Egon!br God bless you on your 95th Birthday! May you complete 100 years.br Being submitted in your honor is a brief article on my continuing work to make available a unique vaccine preventing pregnancy in women without blocking ovulation, her normal production of sex steroid hormones and retaining her regular menstrual cycles and bleeding profiles.br The vaccine is directed at the Human chorionic gonadotropin (hCG), which emerges following fertilization of the egg [1]. Healthy, non-pregnant women do not make it, the basis on which its detection in serum or urine serves as a reliable test for diagnosis of pregnancy. It plays a critical role in implantation of the embryo & thereby to the onset of pregnancy. The purpose of the vaccine is to generate bioeffective antibodies neutralizing hCG & thereby prevent the onset of pregnancy.br As you can imagine, the making of a workable vaccine, competent to make antibodies against a tolerant molecule to the woman’s immune system (she literally bathes in hCG during pregnancy) was not simple. What was also demanded was high immunogenicity of the vaccine to make fairly high titres of antibodies to counteract the large amount of hCG made in early pregnancy. At each stage, it required testing in humans and before that could be done, appropriate toxicology studies & approval of Regulatory and Ethics Committees was needed each taking its time. Eventually the vaccine has to be amenable to industrial production to reach the public, hence a recombinant vaccine had to be developed. Given below is a brief write-up on the evolution of the vaccine against the human chorionic gonadotropin.br Yours, Pran
Date
2015
Type
application/pdf
Identifier
oai:kup.at:13105
http://www.kup.at/kup/pdf/13105.pdf
Collections
OAI Harvested Content

entitlement

 
DSpace software (copyright © 2002 - 2021)  DuraSpace
Quick Guide | Contact Us
Open Repository is a service operated by 
Atmire NV
 

Export search results

The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.